nach oben

Erschienen in:

09.02.2023 | Original Article

Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?

verfasst von: Pei-Hua Wu, Wen-Xuan Huo, Xiao-Dong Mo, Yu Wang, Chen-Hua Yan, Hao Jiang, Meng-Zhu Shen, Xiao-Jun Huang, You-Zhong An

Erschienen in: Annals of Hematology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

The rate of intensive care unit (ICU) mortality in patients with hematologic malignancies is high. The risk factors for this were inconsistent across several previous studies, and there is currently no accepted consensus around risk factors for these patients. We aimed to identify which prognostic factors were associated with ICU mortality in critically ill patients with hematologic malignancies, nearly half of which were allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. In addition, we aimed to compare the characteristics and clinical outcomes of patients with and without allogenic allo-HSCT. In total, 217 patients with hematologic malignancies were enrolled consecutive, 119 (54.8%) of whom underwent HSCT (allo-HSCT: n = 115). All survivors were followed up with until August 1, 2022. The rate of ICU mortality in this cohort was 54.4%: 55.5 and 53.1% for the patients with and without HSCT, respectively (p = 0.724). The probabilities of survival after ICU admission were also comparable between the patients who had allo-HSCT and those who did not. A multivariable analysis revealed that cerebrovascular disease, hyperlactic acidemia on the day of ICU admission, lower platelet count, use of vasoactive drugs, and absence of noninvasive ventilation on the day of ICU admission were independent risk factors for ICU mortality. For patients with three to five of these risk factors, the rate of ICU mortality was as high as 84.6%, which was significantly higher than that of other patients. In this study, the ICU mortality rate in patients with hematologic malignancies was still high, particularly for those with multiple risk factors. However, allo-HSCT was not found to be a risk factor for ICU mortality.

Nur mit Berechtigung zugänglich

Wang Y, Liu QF, Lin R, Yang T, Xu YJ, Mo XD, Huang XJ (2021) Optimizing antithymocyte globulin dosing in haploidentical hematopoietic cell transplantation: long-term follow-up of a multicenter, randomized controlled trial. Sci Bull 66(24):2498–2505. https://doi.org/10.1016/j.scib.2021.06.002CrossRef

Ferreyro BL, Scales DC, Wunsch H, Cheung MC, Gupta V, Saskin R, Thyagu S, Munshi L (2021) Critical illness in patients with hematologic malignancy: a population-based cohort study. Intensive Care Med 47(10):1104–1114. https://doi.org/10.1007/s00134-021-06502-2CrossRefPubMed

Yeo CD, Kim JW, Kim SC, Kim YK, Kim KH, Kim HJ, Lee S, Rhee CK (2012) Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit. J Crit Care 27 (6):739 e731–736 https://doi.org/10.1016/j.jcrc.2012.07.014

Liu J, Cheng Q, Yang Q, Li X, Shen X, Zhang L, Liu Z, Khoshnood K (2015) Prognosis-related factors in intensive care unit (ICU) patients with hematological malignancies: a retrospective cohort analysis in a Chinese population. Hematology 20(9):494–503. https://doi.org/10.1179/1607845414Y.0000000216CrossRefPubMed

Cuthbertson BH, Rajalingam Y, Harrison S, McKirdy F (2008) The outcome of haematological malignancy in Scottish intensive care units. J Intensive Care Soc 9(2):135–140. https://doi.org/10.1177/175114370800900208CrossRef

Azoulay E, Mokart D, Pène F, Lambert J, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Laisne LM, Rabbat A, Lebert C, Perez P, Chaize M, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Darmon M, Schlemmer B, Chevret S, Lemiale V (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium–a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 31(22):2810–2818. https://doi.org/10.1200/jco.2012.47.2365CrossRefPubMed

Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC (2012) Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth 108(3):452–459. https://doi.org/10.1093/bja/aer449CrossRefPubMed

Shen MZ, Li JX, Zhang XH, Xu LP, Wang Y, Liu KY, Huang XJ, Hong SD, Mo XD (2021) Meta-analysis of interleukin-2 receptor antagonists as the treatment for steroid-refractory acute graft-versus-host disease. Front Immunol 12 https://doi.org/10.3389/fimmu.2021.749266

Shen MZ, Hong SD, Wang J, Zhang XH, Xu LP, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Wang JZ, Liu KY, Huang XJ, Mo XD (2022) A predicted model for refractory/recurrent cytomegalovirus infection in acute leukemia patients after haploidentical hematopoietic stem cell transplantation. Front Cell Infect Microbiol 12 https://doi.org/10.3389/fcimb.2022.862526

10.

Liu SN, Zhang XH, Xu LP, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Wang JZ, Liu KY, Huang XJ, Mo XD (2020) Prognostic factors and long-term follow-up of basiliximab for steroid-refractory acute graft-versus-host disease: updated experience from a large-scale study. Am J Hematol 95(8):927–936. https://doi.org/10.1002/ajh.25839CrossRefPubMed

11.

Fan S, Huo WX, Yang Y, Shen MZ, Mo XD (2022) Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: a meta-analysis. Front Immunol 13:954268. https://doi.org/10.3389/fimmu.2022.954268CrossRefPubMedPubMedCentral

12.

Grgic Medic M, Gornik I, Gasparovic V (2015) Hematologic malignancies in the medical intensive care unit–outcomes and prognostic factors. Hematology 20(5):247–253. https://doi.org/10.1179/1607845414Y.0000000206CrossRefPubMed

13.

Irie H, Otake T, Kawai K, Hino M, Namazu A, Shinjo Y, Yamashita S (2017) Prognostic factors in critically ill patients with hematological malignancy admitted to the general intensive care unit: a single-center experience in Japan. J Anesth 31(5):736–743. https://doi.org/10.1007/s00540-017-2390-7CrossRefPubMed

14.

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726. https://doi.org/10.1093/eurheartj/ehab368CrossRefPubMed

15.

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377. https://doi.org/10.1007/s00134-017-4683-6CrossRefPubMed

16.

Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV, Tolwani AJ, Waikar SS, Weisbord SD (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61(5):649–672. https://doi.org/10.1053/j.ajkd.2013.02.349CrossRefPubMed

17.

Flamm SL, Yang YX, Singh S, Falck-Ytter YT (2017) American Gastroenterological Association Institute Guidelines for the diagnosis and management of acute liver failure. Gastroenterology 152(3):644–647. https://doi.org/10.1053/j.gastro.2016.12.026CrossRefPubMed

18.

Bajaj JS, O’Leary JG, Lai JC, Wong F, Long MD, Wong RJ, Kamath PS (2022) Acute-on-chronic liver failure clinical guidelines. Am J Gastroenterol 117(2):225–252. https://doi.org/10.14309/ajg.0000000000001595CrossRefPubMed

19.

Murugan R, Hoste E, Mehta RL, Samoni S, Ding X, Rosner MH, Kellum JA, Ronco C (2016) Precision fluid management in continuous renal replacement therapy. Blood Purif 42(3):266–278. https://doi.org/10.1159/000448528CrossRefPubMed

20.

Abe T, Matsuo H, Abe R, Abe S, Asada H, Ashida A, Baba A, Eguchi K, Eguchi Y, Endo Y, Fujimori Y, Furuichi K, Furukawa Y, Furuya M, Furuya T, Hanafusa N, Hara W, Harada-Shiba M, Hasegawa M, Hattori N, Hattori M, Hidaka S, Hidaka T, Hirayama C, Ikeda S, Imamura H, Inoue K, Ishizuka K, Ishizuka K, Ito T, Iwamoto H, Izaki S, Kagitani M, Kaneko S, Kaneko N, Kanekura T, Kitagawa K, Kusaoi M, Lin Y, Maeda T, Makino H, Makino S, Matsuda K, Matsugane T, Minematsu Y, Mineshima M, Miura K, Miyamoto K, Moriguchi T, Murata M, Naganuma M, Nakae H, Narukawa S, Nohara A, Nomura K, Ochi H, Ohkubo A, Ohtake T, Okada K, Okado T, Okuyama Y, Omokawa S, Oji S, Sakai N, Sakamoto Y, Sasaki S, Sato M, Seishima M, Shiga H, Shimohata H, Sugawara N, Sugimoto K, Suzuki Y, Suzuki M, Tajima T, Takikawa Y, Tanaka S, Taniguchi K, Tsuchida S, Tsukamoto T, Tsushima K, Ueda Y, Wada T, Yamada H, Yamada H, Yamaka T, Yamamoto K, Yokoyama Y, Yoshida N, Yoshioka T, Yamaji K (2021) The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis. Ther Apher Dial 25(6):728–876. https://doi.org/10.1111/1744-9987.13749CrossRefPubMed

21.

Nava S, Hill N (2009) Non-invasive ventilation in acute respiratory failure. Lancet 374(9685):250–259. https://doi.org/10.1016/s0140-6736(09)60496-7CrossRefPubMedPubMedCentral

22.

Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, Navalesi PMOTSC, Antonelli M, Brozek J, Conti G, Ferrer M, Guntupalli K, Jaber S, Keenan S, Mancebo J, Mehta S, Raoof SMOTTF (2017) Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 50 (2)https://doi.org/10.1183/13993003.02426-2016

23.

Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C (2016) Prevention and treatment of cancer-related infections, version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 14(7):882–913. https://doi.org/10.6004/jnccn.2016.0093CrossRefPubMed

24.

Gauzit R, Castan B, Bonnet E, Bru JP, Cohen R, Diamantis S, Faye A, Hitoto H, Issa N, Lebeaux D, Lesprit P, Maulin L, Poitrenaud D, Raymond J, Strady C, Varon E, Verdon R, Vuotto F, Welker Y, Stahl JP (2021) Anti-infectious treatment duration: the SPILF and GPIP French guidelines and recommendations. Infect Dis Now 51(2):114–139. https://doi.org/10.1016/j.idnow.2020.12.001CrossRefPubMed

25.

Garcia Borrega J, Heger JM, Koehler P, Holtick U, Hallek M, Scheid C, Böll B, Shimabukuro-Vornhagen A, Kochanek M, Eichenauer DA (2022) Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospital. Ann Hematol 101(2):389–395. https://doi.org/10.1007/s00277-021-04698-3CrossRefPubMed

26.

Darmon M, Bourmaud A, Georges Q, Soares M, Jeon K, Oeyen S, Rhee CK, Gruber P, Ostermann M, Hill QA, Depuydt P, Ferra C, Toffart AC, Schellongowski P, Müller A, Lemiale V, Mokart D, Azoulay E (2019) Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med 45(7):977–987. https://doi.org/10.1007/s00134-019-05653-7CrossRefPubMed

27.

Zhang XH, Chen J, Han MZ, Huang H, Jiang EL, Jiang M, Lai YR, Liu DH, Liu QF, Liu T, Ren HY, Song YP, Sun ZM, Tang XW, Wang JM, Wu DP, Xu LP, Zhang X, Zhou DB, Huang XJ (2021) The consensus from the Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol 14(1):145. https://doi.org/10.1186/s13045-021-01159-2CrossRefPubMedPubMedCentral

28.

Mo XD, Hong SD, Zhao YL, Jiang EL, Chen J, Xu Y, Sun ZM, Zhang WJ, Liu QF, Liu DH, Wan DM, Mo WJ, Ren HY, Yang T, Huang H, Zhang X, Wang XN, Song XM, Gao SJ, Wang X, Chen Y, Xu B, Jiang M, Huang XB, Li X, Zhang HY, Wang HT, Wang Z, Niu T, Wang JS, Xia LH, Liu XD, Li F, Zhou F, Lang T, Hu J, Wu SJ, Huang XJ (2022) Basiliximab for steroid-refractory acute graft-versus-host disease: a real-world analysis. Am J Hematol 97(4):458–469. https://doi.org/10.1002/ajh.26475CrossRefPubMed

29.

Mo XD, Zhang XH, Xu LP, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Wang JZ, Liu KY, Huang XJ (2021) Disease risk comorbidity index for patients receiving haploidentical allogeneic hematopoietic transplantation. Engineering 7(2):162–169. https://doi.org/10.1016/j.eng.2020.12.005CrossRef

30.

Shen MZ, Zhang XH, Xu LP, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Wang JZ, Zhao XS, Qin YZ, Chang YJ, Liu KY, Huang XJ, Mo XD (2022) Preemptive interferon-α therapy could protect against relapse and improve survival of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation: long-term results of two registry studies. Front Immunol 13 https://doi.org/10.3389/fimmu.2022.757002

31.

Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA (2003) Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 31(1):104–112. https://doi.org/10.1097/00003246-200301000-00017CrossRefPubMed

32.

Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C, Chevret S, Le Gall JR, Brochard L, Schlemmer B (2001) Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 29(3):519–525. https://doi.org/10.1097/00003246-200103000-00009CrossRefPubMed

33.

Benoit DD, Depuydt PO (2010) Non-invasive ventilation in patients with hematological malignancies: the saga continues, but where is the finale? Intensive Care Med 36(10):1633–1635. https://doi.org/10.1007/s00134-010-1949-7CrossRefPubMed

34.

Marik PE (2007) Noninvasive positive-pressure ventilation in patients with malignancy. Am J Hosp Palliat Care 24(5):417–421. https://doi.org/10.1177/1049909107307370CrossRefPubMed

35.

Vitacca M, Ambrosino N, Clini E, Porta R, Rampulla C, Lanini B, Nava S (2001) Physiological response to pressure support ventilation delivered before and after extubation in patients not capable of totally spontaneous autonomous breathing. Am J Respir Crit Care Med 164(4):638–641. https://doi.org/10.1164/ajrccm.164.4.2010046CrossRefPubMed

36.

Ambrosino N, Vagheggini G (2008) Noninvasive positive pressure ventilation in the acute care setting: where are we? Eur Respir J 31(4):874–886. https://doi.org/10.1183/09031936.00143507CrossRefPubMed

37.

Hayashi Y, Endoh H, Kamimura N, Tamakawa T, Nitta M (2020) Lactate indices as predictors of in-hospital mortality or 90-day survival after admission to an intensive care unit in unselected critically ill patients. PLoS One 15(3):e0229135. https://doi.org/10.1371/journal.pone.0229135CrossRefPubMedPubMedCentral

38.

Yang Q, Zhang Y, Kong T, Zhang Z, Xiong X, Chen W (2020) Relationship between “1-hour serum lactate” level and 30-day mortality in critical care patients in intensive care unit. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 32(6):737–742. https://doi.org/10.3760/cma.j.cn121430-20200116-00136CrossRefPubMed

39.

Schork A, Moll K, Haap M, Riessen R, Wagner R (2021) Course of lactate, pH and base excess for prediction of mortality in medical intensive care patients. PLoS One 16(12):e0261564. https://doi.org/10.1371/journal.pone.0261564CrossRefPubMedPubMedCentral

40.

Sauer CM, Gómez J, Botella MR, Ziehr DR, Oldham WM, Gavidia G, Rodríguez A, Elbers P, Girbes A, Bodi M, Celi LA (2021) Understanding critically ill sepsis patients with normal serum lactate levels: results from U.S. and European ICU cohorts. Sci Rep 11(1):20076. https://doi.org/10.1038/s41598-021-99581-6CrossRefPubMedPubMedCentral

41.

Andersen LW, Mackenhauer J, Roberts JC, Berg KM, Cocchi MN, Donnino MW (2013) Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc 88(10):1127–1140. https://doi.org/10.1016/j.mayocp.2013.06.012CrossRefPubMed

42.

Sillos EM, Shenep JL, Burghen GA, Pui CH, Behm FG, Sandlund JT (2001) Lactic acidosis: a metabolic complication of hematologic malignancies: case report and review of the literature. Cancer 92(9):2237–2246. https://doi.org/10.1002/1097-0142(20011101)92:9%3c2237::aid-cncr1569%3e3.0.co;2-9CrossRefPubMed

43.

Friedenberg AS, Brandoff DE, Schiffman FJ (2007) Type B lactic acidosis as a severe metabolic complication in lymphoma and leukemia: a case series from a single institution and literature review. Medicine (Baltimore) 86(4):225–232. https://doi.org/10.1097/MD.0b013e318125759aCrossRefPubMed

44.

Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H (2000) Thrombocytopenia and prognosis in intensive care. Crit Care Med 28(6):1871–1876. https://doi.org/10.1097/00003246-200006000-00031CrossRefPubMed

45.

Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG (2002) Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 30(8):1765–1771. https://doi.org/10.1097/00003246-200208000-00015CrossRefPubMed

46.

Stéphan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A (1999) Thrombocytopenia in a surgical ICU. Chest 115(5):1363–1370. https://doi.org/10.1378/chest.115.5.1363CrossRefPubMed

47.

Crowther MA, Cook DJ, Meade MO, Griffith LE, Guyatt GH, Arnold DM, Rabbat CG, Geerts WH, Warkentin TE (2005) Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care 20(4):348–353. https://doi.org/10.1016/j.jcrc.2005.09.008CrossRefPubMed

48.

Santoshi RK, Patel R, Patel NS, Bansro V, Chhabra G (2022) A comprehensive review of thrombocytopenia with a spotlight on intensive care patients. Cureus 14(8):e27718. https://doi.org/10.7759/cureus.27718CrossRefPubMedPubMedCentral

49.

Wang R, Dai H (2022) Association of platelet count with all-cause mortality from acute respiratory distress syndrome: a cohort study. J Clin Lab Anal 36(5):e24378. https://doi.org/10.1002/jcla.24378CrossRefPubMedPubMedCentral

50.

Lee HH, Hong SJ, Ahn CM, Yang JH, Gwon HC, Kim JS, Kim BK, Ko YG, Choi D, Hong MK, Jang Y (2020) Clinical implications of thrombocytopenia at cardiogenic shock presentation: data from a multicenter registry. Yonsei Med J 61(10):851–859. https://doi.org/10.3349/ymj.2020.61.10.851CrossRefPubMedPubMedCentral

51.

Sexton T, Chalhoub G, Ye S, Morris W, Annabathula R, Dugan A, Smyth S (2020) Autotaxin activity predicts 30-day mortality in sepsis patients and correlates with platelet count and vascular dysfunction. Shock 54(6):738–743. https://doi.org/10.1097/shk.0000000000001569CrossRefPubMed

52.

Slichter SJ (2011) New thoughts on the correct dosing of prophylactic platelet transfusions to prevent bleeding. Curr Opin Hematol 18(6):427–435. https://doi.org/10.1097/MOH.0b013e32834babf4CrossRefPubMed

53.

Greinacher A, Selleng K (2010) Thrombocytopenia in the intensive care unit patient. Hematol Am Soc Hematol Educ Program 2010:135–143. https://doi.org/10.1182/asheducation-2010.1.135CrossRef

Titel: Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?
verfasst von: Pei-Hua Wu
Wen-Xuan Huo
Xiao-Dong Mo
Yu Wang
Chen-Hua Yan
Hao Jiang
Meng-Zhu Shen
Xiao-Jun Huang
You-Zhong An
Publikationsdatum: 09.02.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Annals of Hematology / Ausgabe 4/2023
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-023-05118-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2023

Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database

Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience

Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen

Neonatal hematological parameters: the translational aspect of developmental hematopoiesis

How I manage anemia related to myelofibrosis and its treatment regimens